We eliminated our position in Merck (MRK, Financial) as the shares appreciated to our estimate of fair value.
From Bill Nygren (Trades, Portfolio)'s Oakmark Fund first quarter 2014 commentary.
We eliminated our position in Merck (MRK, Financial) as the shares appreciated to our estimate of fair value.
From Bill Nygren (Trades, Portfolio)'s Oakmark Fund first quarter 2014 commentary.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey